熱門資訊> 正文

UroGen Pharma开始公开发行普通股

2024-06-18 05:10

UroGen Pharma (NASDAQ:URGN) on Monday announced that it commenced an underwritten public offering to issue and sell its ordinary shares and pre-funded warrants.
There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.
All the ordinary shares and pre-funded warrants to be sold in the proposed offering will be offered by UroGen.
URGN -3.34% after hours to $17.67
Source: Press Release

More on UroGen Pharma

UroGen: Q3 NDA Opens Hefty Revenue Opportunity
UroGen Pharma Ltd. (URGN) Q1 2024 Earnings Call Transcript
UroGen surges on updated late-stage data for bladder cancer therapy
Urogen files patent suit against Teva over cancer therapy
Seeking Alpha’s Quant Rating on UroGen Pharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。